Sinina, Venilla .

HRN: 00-17-14  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2025
CEFUROXIME 1.5GM (VIAL)
10/24/2025
10/24/2025
IV
1.5 G
PTOR
For TAH With Mole In Situ Tomorrow
Checking Final Appropriateness 
10/24/2025
CIPROFLOXACIN 500MG (TAB)
10/24/2025
10/26/2025
PO
500 Mg
Every 8 Hours
For TAH With Mole In Situ Tomorrow
Checking Final Appropriateness 
10/24/2025
METRONIDAZOLE 500MG (TAB)
10/24/2025
10/26/2025
PO
500 Mg
Every 8 Hours
For TAH With Mole In Situ Tomorrow
Checking Final Appropriateness 
10/27/2025
CEFAZOLIN 1GM (VIAL)
10/27/2025
10/27/2025
IV
2g
PTOR
Pre Op Prophylaxis
Checking Final Appropriateness 
10/27/2025
CEFUROXIME 500MG (TAB)
10/27/2025
11/03/2025
PO
500mg
BID X 7 Days
S/P TAHBSO
Checking Final Appropriateness 
10/27/2025
MUPIROCIN 2%, 15G (TUBE)
10/27/2025
11/03/2025
TOPICAL
15g
BID
S/P TAHBSO
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: